See the DrugPatentWatch profile for Valtoco
Valtoco is a brand name for diazepam nasal spray, used for the acute treatment of intermittent explosive disorder (IED) and the treatment of seizures [1].
How is Valtoco administered?
Valtoco is administered nasally [1].
What is Valtoco used to treat?
Valtoco is used for the acute treatment of intermittent explosive disorder (IED) and for the treatment of seizures [1].
Who makes Valtoco?
Valtoco is manufactured by Neurelis, Inc. [1].
When does Valtoco's patent expire?
Information regarding Valtoco's specific patent expiry dates is not publicly available within the provided context, but patent information for pharmaceuticals can be tracked through resources like DrugPatentWatch.com [2].
What are the alternatives to Valtoco for seizure treatment?
Diazepam, the active ingredient in Valtoco, is available in various forms for seizure treatment, including rectal gel and injectable solutions. Other benzodiazepines and anti-epileptic drugs are also used to manage seizures [3].
What is intermittent explosive disorder (IED)?
Intermittent explosive disorder (IED) is a behavioral disorder characterized by recurrent, impulsive aggressive outbursts that are grossly out of proportion to the situation or provocation [1].